CVS HEALTH CORPORATION Separate Account Liability Increase Decrease From Invested Performance
CVS HEALTH CORPORATION (CVS) reported Separate Account Liability Increase Decrease From Invested Performance of $84.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Financial Services › Insurance
us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance · last filed 2026-02-10
- CVS HEALTH CORPORATION separate account liability increase decrease from invested performance for the quarter ending 2025-12-31 was $90.00M, a 328.57% increase year-over-year.
- CVS HEALTH CORPORATION separate account liability increase decrease from invested performance for the quarter ending 2025-09-30 was $96.00M, a 53.40% decline year-over-year.
- CVS HEALTH CORPORATION separate account liability increase decrease from invested performance for the quarter ending 2025-06-30 was -$41.00M.
- CVS HEALTH CORPORATION separate account liability increase decrease from invested performance for the quarter ending 2025-03-31 was -$61.00M, a 147.66% decline year-over-year.
- CVS HEALTH CORPORATION separate account liability increase decrease from invested performance for fiscal 2025 was $84.00M, a 75.86% decline from fiscal 2024.
- CVS HEALTH CORPORATION separate account liability increase decrease from invested performance for fiscal 2024 was $348.00M, a 248.00% increase from fiscal 2023.
- CVS HEALTH CORPORATION separate account liability increase decrease from invested performance for fiscal 2023 was $100.00M.
- CVS HEALTH CORPORATION separate account liability increase decrease from invested performance for fiscal 2022 was -$1.13B.
| Period end | Separate Account Liability Increase Decrease From Invested Performance 3 month | Separate Account Liability Increase Decrease From Invested Performance 6 month | Separate Account Liability Increase Decrease From Invested Performance 9 month | Separate Account Liability Increase Decrease From Invested Performance 12 month |
|---|---|---|---|---|
| 2025-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $186.00M derived: sum of 2 quarters · filed 2026-02-10 | $145.00M derived: sum of 3 quarters · filed 2026-02-10 | $84.00M 10-K · filed 2026-02-10 |
| 2025-09-30 | $96.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $55.00M derived: sum of 2 quarters · filed 2025-10-29 | -$6.00M 10-Q · filed 2025-10-29 | $15.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2025-06-30 | -$41.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$102.00M 10-Q · filed 2025-07-31 | -$81.00M derived: sum of 3 quarters · filed 2026-02-10 | $125.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2025-03-31 | -$61.00M 10-Q · filed 2025-05-01 | -$40.00M derived: sum of 2 quarters · filed 2026-02-10 | $166.00M derived: sum of 3 quarters · filed 2026-02-10 | $159.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $227.00M derived: sum of 2 quarters · filed 2026-02-10 | $220.00M derived: sum of 3 quarters · filed 2026-02-10 | $348.00M 10-K · filed 2026-02-10 |
| 2024-09-30 | $206.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $199.00M derived: sum of 2 quarters · filed 2025-10-29 | $327.00M 10-Q · filed 2025-10-29 | $385.00M derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $121.00M 10-Q · filed 2025-07-31 | $179.00M derived: sum of 3 quarters · filed 2025-07-31 | $133.00M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $128.00M 10-Q · filed 2025-05-01 | $186.00M derived: sum of 2 quarters · filed 2025-05-01 | $140.00M derived: sum of 3 quarters · filed 2025-05-01 | $205.00M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $58.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $12.00M derived: sum of 2 quarters · filed 2025-02-12 | $77.00M derived: sum of 3 quarters · filed 2025-02-12 | $100.00M 10-K · filed 2025-02-12 |
| 2023-09-30 | -$46.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $19.00M derived: sum of 2 quarters · filed 2024-11-06 | $42.00M 10-Q · filed 2024-11-06 | -$31.00M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $65.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $88.00M 10-Q · filed 2024-08-07 | $15.00M derived: sum of 3 quarters · filed 2024-08-07 | -$132.00M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $23.00M 10-Q · filed 2024-05-01 | -$50.00M derived: sum of 2 quarters · filed 2024-05-01 | -$197.00M derived: sum of 3 quarters · filed 2024-05-01 | -$714.00M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | -$73.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$220.00M derived: sum of 2 quarters · filed 2024-02-07 | -$737.00M derived: sum of 3 quarters · filed 2024-02-07 | -$1.13B 10-K · filed 2024-02-07 |
| 2022-09-30 | -$147.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$664.00M derived: sum of 2 quarters · filed 2023-11-01 | -$1.06B 10-Q · filed 2023-11-01 | |
| 2022-06-30 | -$517.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$910.00M 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | -$393.00M 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $53.00M 8-K · filed 2023-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |